Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?
about
Prostate MRI - an update for the referring urologistLimitations and Prospects for Diffusion-Weighted MRI of the ProstateMultiparametric magnetic resonance imaging for prostate cancer: A review and update for urologistsTargeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancerMultiparametric-MRI in diagnosis of prostate cancerIntegration of multiparametric MRI into active surveillance of prostate cancer.Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer.Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.Detection of prostate cancer using temporal sequences of ultrasound data: a large clinical feasibility study.Review of Prostate Imaging Reporting and Data System version 2.Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Multiparametric magnetic resonance imaging of the prostate aids detect lesion progressionTargeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.Multiparametric MRI in the PSA screening eraOptimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessmentThe role of MRI in prostate cancer active surveillance.The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillanceProstate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR ImagingRisk stratification of prostate cancer in the modern era.Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.Impact of an Information Technology-Enabled Initiative on the Quality of Prostate Multiparametric MRI ReportsIdentification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline.The role of magnetic resonance imaging in delineating clinically significant prostate cancerDiagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies.Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").Multiparametric MRI for localized prostate cancer: lesion detection and staging.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance.Role of prostate magnetic resonance imaging in active surveillance.Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations.Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.Prostate cancer risk stratification with magnetic resonance imaging.Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.
P2860
Q26739725-304AE835-49A8-4742-B044-B6EF5139C92FQ26744802-A3C58C13-BFC0-41EB-993F-16299B6373FCQ26801576-942750E0-4DE6-4DC7-9876-3F48A458DAC3Q27027567-98EC9132-DC55-42D8-A336-A17D721DBBE9Q28081873-04A1DF82-316E-49B2-9877-C5931BC9A433Q30249514-BBBD6753-BAA8-4D47-8F04-03CAC91C2CC8Q30664726-89F2E2AF-3E28-41DC-ABF2-0C75BF49CB8FQ30843143-EB3D6013-05C6-47ED-B41C-52774A7FD9C6Q30882787-78A08291-1032-42A1-BB2D-51973B089FC1Q31072087-13CB0335-1249-431D-89B8-FB0B10A6413CQ31131775-8B30A63D-A443-4660-B6AC-BC9281DA04B4Q33783620-BB11BD9F-6409-406C-B0ED-9D9E5A932F12Q33911317-5159659F-F29B-4165-9FAF-C045806BBB04Q34032598-B3A850C0-3C49-4612-9286-7CF9BD694AA9Q34084254-F8E74DB7-E91D-48FE-BB10-378C6075C560Q34177428-599C02C6-9D88-4821-AF71-0744E0F9FB75Q34475350-34C1E97B-BA52-4821-A938-D67F6CDA3752Q34705261-3DE3281C-1DEC-4569-803D-C8EE4AE0AD17Q34864876-9026895D-C6A7-43E3-8CFF-D7E53C31DC42Q35670525-86A73427-15D8-4B28-B2C3-D68E025F8F90Q35680101-96DBF5FA-215C-4431-9F03-FEC5823B36D0Q35720507-C0B65320-4F1F-407E-AF64-4E64655AF83BQ35852107-FA71500F-7090-4BF7-AE92-D36608302204Q36108460-D91A2FA2-82A7-4B4E-8CB7-6E0CE0273836Q36386904-304C53E2-CD1D-4DBB-BCD4-332AEF05C37BQ37029385-DB47E460-2FB3-4C1D-ABD1-3E49FF254830Q37377731-9E952885-3A72-41A5-AC10-750F4CE0419EQ37580674-C4FCFDAE-E274-40A8-ADEF-613DDC868B3FQ38180533-41CC7AE6-F1E2-4EC7-BC61-C1763DB0DF9FQ38193586-480A9373-1DA3-426B-8900-E24C5D3D43FDQ38294503-975925D2-3549-4066-A34E-26E746E3054EQ38321182-61523E39-7C07-4EF5-AA4A-2C87E3D847BDQ38392814-2DD01531-539B-4332-ABB6-F117F6D86319Q38671172-915601AC-6279-4B2A-9ADE-9C6D463563D2Q38716270-54DCB220-7483-4DA6-B76D-41A1ECFD893AQ38786175-A4157E66-6CE7-45EF-BC75-24B99D2F9808Q38796980-AB3E2F96-235C-4217-B1D3-3F7D003A73F3Q38843182-ABE5CFB3-9AEE-4606-AE1A-0570ED1042A7Q38904161-E6F76B6E-3B7A-4EA2-ACBF-60E028B372CBQ39108592-3507B296-521B-435A-A0A8-17AD9427D788
P2860
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prostate cancer: can multipara ...... dates for active surveillance?
@en
type
label
Prostate cancer: can multipara ...... dates for active surveillance?
@en
prefLabel
Prostate cancer: can multipara ...... dates for active surveillance?
@en
P2093
P2860
P356
P1433
P1476
Prostate cancer: can multipara ...... dates for active surveillance?
@en
P2093
Anthony Hoang
Aradhana Kaushal
Ardeshir R Rastinehad
Baris Turkbey
Dagane Daar
Haresh Mani
Harsh Agarwal
Jennifer Ho
Marcelino Bernardo
Maria J Merino
P2860
P304
P356
10.1148/RADIOL.13121325
P407
P577
2013-03-06T00:00:00Z